← FDA Drug Approvals (Drugs@FDA)

ORPHENADRINE CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2003-03-04

Drug application

FDA Application #

ANDA040463

Application type

Abbreviated New Drug Application (Generic)

Brand name

ORPHENADRINE CITRATE

Generic name

ORPHENADRINE CITRATE

Active ingredients

ORPHENADRINE CITRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HIKMA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2003-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown